A comprehensive listing of bioactivation pathways of organic functional groups

AS Kalgutkar, I Gardner, RS Obach… - Current drug …, 2005 - ingentaconnect.com
The occurrence of idiosyncratic adverse drug reactions during late clinical trials or after a
drug has been released can lead to a severe restriction in its use and even in its withdrawal. …

Vascular complications of diabetes

R Donnelly, AM Emslie-Smith, ID Gardner, AD Morris - Bmj, 2000 - bmj.com
Adults with diabetes have an annual mortality of about 5.4%(double the rate for non-diabetic
adults), and their life expectancy is decreased on average by 5-10 years. Although the …

Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist

K Beaumont, R Webster, I Gardner… - Current drug …, 2003 - ingentaconnect.com
Many drugs are administered at sites that are remote from their site of action. The most common
route of drug delivery is the oral route. The optimal physicochemical properties to allow …

Adverse outcome pathways: opportunities, limitations and open questions

…, E Danen, B van Ravenzwaay, H Kamp, I Gardner… - Archives of …, 2017 - Springer
Adverse outcome pathways (AOPs) are a recent toxicological construct that connects, in a
formalized, transparent and quality-controlled way, mechanistic information to apical …

Physiologically based pharmacokinetic model qualification and reporting procedures for regulatory submissions: a consortium perspective

…, N Djebli, HJ Einolf, I Gardner… - Clinical …, 2018 - Wiley Online Library
This work provides a perspective on the qualification and verification of physiologically based
pharmacokinetic (PBPK) platforms/models intended for regulatory submission based on …

[BOOK][B] Manichaean texts from the Roman Empire

I Gardner, SNC Lieu - 2004 - books.google.com
… the concept for the volume and approached Iain Gardner to collaborate, especially with
translations of the extensive Coptic corpus. Gardner began to prepare portions of the Kephalaia …

Pharmacokinetics, pharmacodynamics and physiologically-based pharmacokinetic modelling of monoclonal antibodies

M Dostalek, I Gardner, BM Gurbaxani, RH Rose… - Clinical …, 2013 - Springer
Abstract Development of monoclonal antibodies (mAbs) and their functional derivatives
represents a growing segment of the development pipeline in the pharmaceutical industry. More …

Modelling and PBPK simulation in drug discovery

HM Jones, IB Gardner, KJ Watson - The AAPS journal, 2009 - Springer
Physiologically based pharmacokinetic (PBPK) models are composed of a series of differential
equations and have been implemented in a number of commercial software packages. …

[BOOK][B] The Kephalaia of the Teacher: The edited Coptic Manichaean texts in translation with commentary

I Gardner - 2020 - books.google.com
The Kephalaia of the Teacher is the most detailed account available to modern scholarship
of the teachings of Mani, and of the universal religion that he founded as the final successor …

Zebrafish based assays for the assessment of cardiac, visual and gut function—potential safety screens for early drug discovery

…, P Butler, P Goldsmith, G Waldron, I Gardner… - … of pharmacological and …, 2008 - Elsevier
INTRODUCTION: Safety pharmacology is integral to the non-clinical safety assessment of
new chemical entities prior to first administration to humans. The zebrafish is a well …